Hill-Rom completes takeover of Mortara Instrument

Hill-Rom has announced the completion of its acquisition of Mortara Instrument, a move that will considerably strengthen its position in cardiac and vitals monitoring.

The $330 million (265.11 million pounds) deal is expected to accelerate Hill-Rom's revenue and earnings growth, with the company set to issue updated financial guidance during its second quarter earnings announcement.

Mortara offers a wide range of diagnostic cardiology devices under the Mortara, Quinton and Burdick brands, including tools for resting electrocardiography, cardiac stress exercise, Holter monitoring and ambulatory blood pressure monitoring applications.

The company is based in Milwaukee with offices in Australia, Italy, Germany, the Netherlands and the UK, with more than 400 staff members employed globally.

Following the completion of the deal, Mortara Instrument chief executive Dr Justin Mortara has joined Hill-Rom and will continue to lead the business, reporting to Hill-Rom's front line care president Alton Shader.

John Greisch, president and chief executive officer of Hill-Rom, said: "We look forward to advancing our combined diagnostic cardiology and vitals monitoring capabilities for patients and their caregivers."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.